Cello Group plc (LON:CLL) Rating Reiterated by FinnCap

Cello Group plc (LON:CLL)‘s stock had its “buy” rating reiterated by analysts at FinnCap in a report released on Monday, June 19th. They currently have a GBX 132 ($1.72) target price on the stock. FinnCap’s target price points to a potential upside of 5.18% from the company’s previous close.

Separately, N+1 Singer restated a “buy” rating and set a GBX 131 ($1.71) target price on shares of Cello Group plc in a report on Wednesday, March 22nd.

Shares of Cello Group plc (LON:CLL) remained flat at GBX 125.50 during trading on Monday. 23,096 shares of the company’s stock traded hands. The firm’s market capitalization is GBX 109.36 million. Cello Group plc has a 52 week low of GBX 94.60 and a 52 week high of GBX 140.00. The firm’s 50-day moving average is GBX 132.22 and its 200 day moving average is GBX 118.06.

WARNING: “Cello Group plc (LON:CLL) Rating Reiterated by FinnCap” was published by Sports Perspectives and is the property of of Sports Perspectives. If you are reading this piece on another site, it was stolen and republished in violation of United States & international trademark & copyright legislation. The correct version of this piece can be accessed at https://sportsperspectives.com/2017/07/18/cello-group-plc-cll-receives-buy-rating-from-finncap-updated-updated-updated.html.

Cello Group plc Company Profile

Cello Group plc is a United Kingdom-based healthcare and consumer strategic marketing company. The Company is engaged in providing market research, consulting and direct marketing services. The Company operates through two segments: Cello Health and Cello Signal. The Cello Health Division provides market research, consulting and communications services principally to the Company’s pharmaceutical and healthcare clients.

Receive News & Ratings for Cello Group plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cello Group plc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply